Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07574450

Taiwan ED Airway Quality Surveillance Registry (TEAR)

This prospective, multicenter observational registry systematically captures all emergency department tracheal intubations across participating hospitals in Taiwan. The registry focuses on process quality indicators, including first-pass success, and patient-safety outcomes, including hypoxemia, hypotension, and peri-intubation cardiac arrest within 30 minutes of intubation. Routinely generated laboratory and physiologic variables are also collected to improve risk stratification and identify predictors of major adverse events. The study is non-interventional and does not alter clinical care.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Airway Management Cardiovascular Diseases Disease Attributes Emergencies Emergency Department Heart Arrest Heart Diseases Hypotension Hypoxia Pathologic Processes Pathological Conditions, Signs and Symptoms Peri-intubation Adverse Events Signs and Symptoms Signs and Symptoms, Respiratory Tracheal Intubation Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan

New Taipei City, Taiwan

Location contact

TING HAO YANG, Doctor

CONTACT

[email protected]

+886978989007

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Undergoing tracheal intubation in the emergency department during the study period

Exclusion criteria

  • Prehospital intubation; intubation performed solely for elective anesthesia/procedural sedation outside emergency indications

Treatment and study plan

Primary outcomes

  1. Incidence of major adverse peri-intubation events within 30 minutes after the start of intubation

    Time frame: Periprocedural, through 30 minutes after the start of intubation

    severe hypoxemia, severe hypotension/cardiovascular instability, or cardiac arrest.

Secondary outcomes

  1. First-pass success

    Time frame: Periprocedural

  2. In-hospital mortality

    Time frame: From intubation to hospital discharge, assessed up to 90 days

Other outcomes

  1. Pre-intubation severe metabolic acidosis

    Time frame: Within 2 hours before the start of intubation

Study contacts

Contact information is provided by the study sponsor or research team.

TING HAO YANG, Doctor

CONTACT

[email protected]

+886978989007

Sponsors and collaborators

Lead sponsor

Chang Gung Memorial Hospital

Other

Registry information

Official study title

The Taiwan ED Airway Quality Surveillance Registry (TEAR): A Prospective Multicenter Observational Study

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
May 8, 2026
Registry last updated
May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.